Study Finds Statins Erase Cholesterol Gap for Obese Adults Over 40 Across 7 Countries
Updated
Updated · The Guardian · Jul 2
Study Finds Statins Erase Cholesterol Gap for Obese Adults Over 40 Across 7 Countries
3 articles · Updated · The Guardian · Jul 2
Summary
Nearly 1 million adults' data showed people with obesity aged 40 and over now often have cholesterol and blood pressure levels indistinguishable from healthy-weight peers, and in some countries were sometimes better off.
Statins and blood pressure drugs drove the shift, with larger declines in non-HDL cholesterol and systolic blood pressure among obese adults than among those with normal BMI.
110 health surveys from 1990 to 2024 across England, the US, Japan, South Korea, Taiwan, Thailand and Finland underpinned the Lancet study.
Adults under 40 with obesity still had higher bad cholesterol and blood pressure, prompting researchers to call for earlier lifestyle intervention, screening and treatment.
Researchers said the findings help frame the cardiovascular profile of people likely to receive fast-rising weight-loss drugs, while stressing obesity still raises risks for diabetes, kidney disease and some cancers.
If drugs fix cholesterol and blood pressure, what hidden heart risks from obesity still remain?
With risks appearing earlier, what is the critical window to prevent lifelong disease from obesity?
Are we winning the battle against symptoms while losing the war on obesity itself?
Statins and Antihypertensives Close Cardiovascular Risk Gap in Older Obese Adults, But Challenges Remain for Younger Populations
Overview
A landmark study published by Imperial College London in 2026 revealed a major shift in cardiovascular health for older obese adults. Researchers found that the long-standing gap in cholesterol and blood pressure between obese adults over 40 and those with normal BMI has effectively disappeared, especially in people aged 60 to 79. This improvement is linked to targeted interventions and better healthcare management, which have helped control traditional risk factors. However, the study also showed that younger adults under 40 did not experience this benefit, likely due to less consistent screening for high blood pressure and cholesterol, which often go unnoticed in early stages.